Basit öğe kaydını göster

Galectin-3 as a potential biomarker in colorectal cancer?

dc.contributor.authorGuven, H.
dc.contributor.authorSivrikoz, T. S.
dc.contributor.authorErturk, M. O.
dc.contributor.authorKamali, G. H.
dc.contributor.authorYilmaz, E.
dc.contributor.authorKamali, S.
dc.contributor.authorSivrikoz, E.
dc.date.accessioned2021-03-03T09:51:33Z
dc.date.available2021-03-03T09:51:33Z
dc.date.issued2015
dc.identifier.citationKamali S., Yilmaz E., Sivrikoz E., Erturk M. O. , Kamali G. H. , Sivrikoz T. S. , Guven H., "Galectin-3 as a potential biomarker in colorectal cancer?", EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, cilt.47, sa.5, ss.254-257, 2015
dc.identifier.issn1682-8631
dc.identifier.otherav_1f4937dc-0d6d-4755-906b-a154c1b1b880
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/26167
dc.identifier.urihttps://doi.org/10.1007/s10353-015-0344-6
dc.description.abstractBackground Colorectal cancer incidence is inclining in the past decades, and diagnosis relies mainly on colonoscopic screening. Galectin-3 is recently shown to be associated with colorectal cancer. This study aimed to correlate serum galectin-3 levels with pathologically proven colorectal cancer.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectCERRAHİ
dc.subjectKlinik Tıp
dc.subjectTıp
dc.subjectCerrahi Tıp Bilimleri
dc.titleGalectin-3 as a potential biomarker in colorectal cancer?
dc.typeMakale
dc.relation.journalEUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA
dc.contributor.departmentIstanbul Okmeydani Training & Research Hospital , ,
dc.identifier.volume47
dc.identifier.issue5
dc.identifier.startpage254
dc.identifier.endpage257
dc.contributor.firstauthorID224938


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster